Career history of Nelson Chau
Former positions of Nelson Chau
| Companies | Position | Start | End |
|---|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2017-08-31 | 2021-04-30 |
| REGULUS THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - | - |
| TRANSLATE BIO, INC. | Corporate Officer/Principal | - | - |
Training of Nelson Chau
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Nelson Chau
- Experience
